Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Brain & Neurology

Antioxidant Role of PRGF on RPE Cells after Blue Light Insult as a Therapy for Neurodegenerative Diseases

The results show that PRGF reduces light insult by stimulating the cell response against oxidative damage and modulates the antioxidant pathway.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors studied whether plasma rich in growth factors (PRGF) protects retinal pigment epithelial cells from blue light damage, using a human cell line and rat retinal tissue. They report that PRGF reduced light-induced damage by stimulating antioxidant responses. The study was conducted in cell and tissue models, so the authors suggest possible future use for conditions such as age-related macular degeneration without showing clinical benefit.

Who or what was studied
ARPE19 human retinal epithelial cell line and rat retinal pigment epithelium (ex vivo)
Limits stated in the abstract
The findings come from in vitro and ex vivo models, not human participants, so clinical effectiveness is not established.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Oxidative stress has a strong impact on the development of retinal diseases such as age-related macular degeneration (AMD). Plasma rich in growth factors (PRGF) is a novel therapeutic approach in ophthalmological pathologies. The aim of this study was to analyze the antioxidant effect of PRGF in retinal epithelial cells (EPR) in in vitro and ex vivo retinal phototoxicity models. In vitro analyses were performed on ARPE19 human cell line. Viability and mitochondrial status were assessed in order to test the primary effects of PRGF. GSH level, and protein and gene expression of the main antioxidant pathway (Keap1, Nrf2, GCL, HO-1, and NQO1) were also studied. Ex vivo analyses were performed on rat RPE, and HO-1 and Nrf2 gene and protein expression were evaluated. The results show that PRGF reduces light insult by stimulating the cell response against oxidative damage and modulates the antioxidant pathway. We conclude that PRGF's protective effect could prove useful as a new therapy for treating neurodegenerative disorders such as AMD.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Age-related macular degeneration, Oxidative stress. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies